UY33125A - Diaza-espiro-[5,5]-undecanos - Google Patents
Diaza-espiro-[5,5]-undecanosInfo
- Publication number
- UY33125A UY33125A UY33125A UY33125A UY33125A UY 33125 A UY33125 A UY 33125A UY 33125 A UY33125 A UY 33125A UY 33125 A UY33125 A UY 33125A UY 33125 A UY33125 A UY 33125A
- Authority
- UY
- Uruguay
- Prior art keywords
- undecanos
- espiro
- diaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2663DE2009 | 2009-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY33125A true UY33125A (es) | 2011-07-29 |
Family
ID=43640117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY33125A UY33125A (es) | 2009-12-21 | 2010-12-21 | Diaza-espiro-[5,5]-undecanos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8530648B2 (https=) |
| EP (1) | EP2516439B1 (https=) |
| JP (1) | JP2013515033A (https=) |
| CN (1) | CN102762567A (https=) |
| AR (1) | AR079553A1 (https=) |
| ES (1) | ES2459496T3 (https=) |
| TW (1) | TW201132642A (https=) |
| UY (1) | UY33125A (https=) |
| WO (1) | WO2011076747A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120101110A1 (en) * | 2010-10-26 | 2012-04-26 | Sangamesh Badiger | Diaza-spiro[5.5]undecanes |
| US20120165331A1 (en) * | 2010-12-22 | 2012-06-28 | Sangamesh Badiger | Di/tri-aza-spiro-C9-C11alkanes |
| US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
| ES2672732T3 (es) | 2012-02-07 | 2018-06-15 | Eolas Therapeutics Inc. | Prolinas/piperidinas sustituidas como antagonistas del receptor de orexina |
| ITMI20120424A1 (it) | 2012-03-19 | 2013-09-20 | Rottapharm Spa | Composti chimici |
| US9365569B2 (en) * | 2014-01-27 | 2016-06-14 | Allergan, Inc. | Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation |
| JP2017100951A (ja) * | 2014-04-04 | 2017-06-08 | 大正製薬株式会社 | オキサゾリジノン及びオキサジナノン誘導体 |
| JP6663909B2 (ja) | 2014-08-13 | 2020-03-13 | エオラス セラピューティクス， インコーポレイテッド | オレキシンレセプターモジュレーターとしてのジフルオロピロリジン |
| WO2017012502A1 (en) | 2015-07-17 | 2017-01-26 | Sunshine Lake Pharma Co., Ltd. | Substituted quinazoline compounds and preparation and uses thereof |
| MX2018009656A (es) | 2016-02-12 | 2019-02-20 | Astrazeneca Ab | Piperidinas halo-sustituidas como moduladores de los receptores de orexinas. |
| JP2019527232A (ja) | 2016-08-01 | 2019-09-26 | アプティニックス インコーポレイテッド | スピロ−ラクタムｎｍｄａ修飾因子及びこれを用いた方法 |
| SG10202101055VA (en) | 2016-08-01 | 2021-03-30 | Aptinyx Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| MX385336B (es) | 2016-08-01 | 2025-03-18 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactam y uso de los mismos. |
| CN106831774B (zh) * | 2017-02-07 | 2019-02-01 | 上海合全药业股份有限公司 | 一种(6s，7s)-9-叔丁氧羰基-7-(三氟甲基)-2，9-二氮杂螺[5.5]十一烷的合成方法 |
| CN112204031B (zh) * | 2018-01-31 | 2024-05-24 | 元羿生物科技(香港)有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| WO2020158415A1 (ja) * | 2019-01-28 | 2020-08-06 | サントリーホールディングス株式会社 | オレキシン受容体拮抗阻害用組成物 |
| MX2023001725A (es) | 2020-08-14 | 2023-02-22 | Novartis Ag | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos. |
| JP2024516033A (ja) * | 2021-05-03 | 2024-04-11 | ジャズ ファーマシューティカルズ アイルランド リミテッド | オレキシン受容体アゴニスト及びその使用 |
| US20250243186A1 (en) * | 2021-10-27 | 2025-07-31 | Hansoh Bio Llc | Piperidinyl indole derivatives, preparation methods and medicinal uses thereof |
| WO2023081094A1 (en) * | 2021-11-04 | 2023-05-11 | University Of Washington | Novel spirocyclic compounds as klhdc2 ligands |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| JP4496722B2 (ja) * | 2002-06-28 | 2010-07-07 | 萬有製薬株式会社 | 新規ベンズイミダゾール誘導体 |
| US7105526B2 (en) * | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
| JP2009506061A (ja) * | 2005-08-26 | 2009-02-12 | メルク エンド カムパニー インコーポレーテッド | ジアザスピロデカンオレキシン受容体拮抗薬 |
| WO2007058322A1 (ja) * | 2005-11-18 | 2007-05-24 | Ono Pharmaceutical Co., Ltd. | 塩基性基を含有する化合物およびその用途 |
-
2010
- 2010-12-20 ES ES10805703.5T patent/ES2459496T3/es active Active
- 2010-12-20 WO PCT/EP2010/070263 patent/WO2011076747A1/en not_active Ceased
- 2010-12-20 AR ARP100104775A patent/AR079553A1/es unknown
- 2010-12-20 US US13/517,111 patent/US8530648B2/en not_active Expired - Fee Related
- 2010-12-20 JP JP2012545277A patent/JP2013515033A/ja active Pending
- 2010-12-20 TW TW099144804A patent/TW201132642A/zh unknown
- 2010-12-20 EP EP10805703.5A patent/EP2516439B1/en not_active Not-in-force
- 2010-12-20 CN CN2010800643044A patent/CN102762567A/zh active Pending
- 2010-12-21 UY UY33125A patent/UY33125A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20120264748A1 (en) | 2012-10-18 |
| EP2516439B1 (en) | 2014-01-22 |
| WO2011076747A1 (en) | 2011-06-30 |
| AR079553A1 (es) | 2012-02-01 |
| ES2459496T3 (es) | 2014-05-09 |
| US8530648B2 (en) | 2013-09-10 |
| TW201132642A (en) | 2011-10-01 |
| JP2013515033A (ja) | 2013-05-02 |
| CN102762567A (zh) | 2012-10-31 |
| EP2516439A1 (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2021006I1 (no) | Quofenix, delafloksacin | |
| UY33125A (es) | Diaza-espiro-[5,5]-undecanos | |
| BRPI1010301A2 (pt) | composição. | |
| HRP20151058T1 (xx) | Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe | |
| BRPI1011414A2 (pt) | "método." | |
| BRPI1009789A2 (pt) | desacoplador. | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| IT1396487B1 (it) | Convogliatore. | |
| BRPI0907522A2 (pt) | biarlamidas | |
| BRPI0915562A2 (pt) | tamis melhorado | |
| BRPI0915442A2 (pt) | tamis melhorado | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| DK2442870T3 (da) | Pyrazinooxazepin-derivater. | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
| BRPI0909637A2 (pt) | 2-aminoquinolinas | |
| AT507449A3 (de) | Dämmstoffbefestiger | |
| IT1396642B1 (it) | Statore. | |
| BRPI1011720A2 (pt) | compostos de 1,1,1- tri-flúor-2 hidróxi-propila. | |
| FI20085942A0 (fi) | Kaivo | |
| BRPI1013017A2 (pt) | "17beta-alquil-17alfa-óxi-estratrienos" | |
| FI20095315A0 (fi) | Iskulaite | |
| IT1399653B1 (it) | Apparecchiatura festonatrice. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20181127 |